Comparison of differing dose levels of methotrexate for patients with primary central nervous system lymphoma.

Saved in:
Bibliographic Details
Title: Comparison of differing dose levels of methotrexate for patients with primary central nervous system lymphoma.
Authors: Schrum DP; Department of Pharmacy, Duke University Medical Center, Durham, NC, USA., Moorman MT; Department of Pharmacy, Duke University Medical Center, Durham, NC, USA., Li Z; Department of Biostatistics and Informatics, Duke University School of Medicine, Durham, NC, USA., Dillon M; Department of Biostatistics and Informatics, Duke University School of Medicine, Durham, NC, USA., Peters KB; Department of Neurology, Duke University Medical Center, Durham, NC, USA., McKinney M; Division of Hematologic Malignancies and Cellular Therapies, Department of Medicine, Duke University Medical Center, Durham, NC, USA., Patel MP; Department of Pharmacy, Duke University Medical Center, Durham, NC, USA.
Source: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2024 Apr; Vol. 30 (3), pp. 513-518. Date of Electronic Publication: 2023 May 17.
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1477-092X
DOI:10.1177/10781552231176754